Adverum Biotechnologies
ADVM
ADVM
78 hedge funds and large institutions have $55.6M invested in Adverum Biotechnologies in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0% less ownership
Funds ownership: 5.9% → 5.89% (-0%)
21% less capital invested
Capital invested by funds: $70M → $55.6M (-$14.4M)
62% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 29
Holders
78
Holding in Top 10
2
Calls
$1.29M
Puts
$10K
Top Buyers
| 1 | +$5.31M | |
| 2 | +$1.14M | |
| 3 | +$1.02M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$481K |
| 5 |
CCM
CAAS Capital Management
New York
|
+$128K |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$2.07M | |
| 3 | -$1.26M | |
| 4 |
Two Sigma Advisers
New York
|
-$430K |
| 5 |
JP Morgan Chase
New York
|
-$396K |